Table 2.

Effect of treatments on the blood lipid profile within the total and dyslipidemic participants.

Blood lipid		2a (Overweight and obese subjects)
		C	SE	Ex	Sm
TC	Basal	190±31	196±35	197±38	201±39
	Final	186±31	163±33	177±36	183±37
	p value (n)	0.619 (12)	0.001 (14) *	0.053 (14)	0.103 (12)
TG	Basal	131±31	157±47	139±44	141±37
	Final	125±32	135±37	124±42	127±34
	p value (n)	0.517 (12)	0.070 (14)	0.212 (14)	0.176 (12)
LDL-C	Basal	131±32	128±36	137±38	138±37
	Final	127±30	93±34	115±36	117±38
	p value (n)	0.680 (12)	0.001 (14) *	0.046 (14) *	0.062 (12)
HDL-C	Basal	35±12	34±9	31±9	35±10
	Final	37±8	42±10	36±9	40±11
	p value (n)	0.655 (12)	0.005 (14) *	0.059 (14)	0.071 (12)
Blood lipid		2b (Dyslipidemic subjects)
		C	SE	Ex	Sm
TC	Basal	219±16	226±22	232±23	233±21
	Final	213±18	189±20	208±28	212±23
	p value (n)	0.412 (6)	0.000 (7) *	0.025 (6) *	0.029 (6) *
TG	Basal	160±6	184±40	180±25	167±11
	Final	153±12	156±29	164±21	148±19
	p value (n)	0.156 (6)	0.043 (7) *	0.096 (7)	0.004 (7) *
LDL-C	Basal	140±29	141±29	148±33	148±33
	Final	135±27	101±34	124±33	128±32
	p value (n)	0.650 (9)	0.001 (10) *	0.030 (10) *	0.060 (9)
HDL-C	Basal	28±8	30±6	28±6	29±6
	Final	31±5	40±10	33±6	35±10
	p value (n)	0.172 (7)	0.001 (10) *	0.019 (10) *	0.040 (8) *

Data are expressed as mg·dL⁻¹ and mean ± SD. Asterisk (*) means statistical differences between basal and final blood lipid concentration (p < 0.05). SE: Spirulina and exercise; Ex: Exercise and placebo; Sm: Spirulina without exercise; C: Control (Placebo without exercise); TC: total cholesterol, TG: Triglycerides; LDL-C: low density lipoprotein-cholesterol, HDL-C: high density lipoprotein-cholesterol; n: Sample size.